Drayton has 20 years of experience in the pharmaceutical industry and was most recently at IQVIA for 10 years. Before joining Certara, he was Vice President and Global Head of Sales for the Real World Solutions Global Business Unit at IQVIA. He was responsible for driving all sales teams and marketing activities across the Real World Solutions Business Unit to deliver year on year revenue growth. Drayton has held other commercial leadership roles at IQVIA, including helming the global account team responsible for delivery excellence and revenue growth across all lines of business for a top 5 global biopharmaceutical company, leading business development in the US and Canada, and heading up business development in the Asia Pacific region while residing in Singapore.
Prior to joining IQVIA in 2011, Drayton was the head of investor relations at Talecris Biotherapeutics, where he built and managed the IR function post the company’s IPO and through its acquisition by Grifols. While at Talecris, he also ran the commercial organization for a portfolio of specialty immune globulins. Previously, Drayton was an executive with GlaxoSmithKline in marketing and sales.
Drayton has a bachelor’s degree in chemistry from Washington and Lee University and an MBA from Duke University’s Fuqua School of Business.